Formulations:
- Parenteral > General injections > unspecified: 10 mg in vial powder for injection; 50 mg in vial powder for injection
Parenteral > General injections > IV: 10 mg per 10 mL; 20 mg per 20 mL; 50 mg per 50 mL; 100 mg per 100 mL
Parenteral > General injections > IV: 50 mg per 50 mL; 100 mg per 100 mL; 10 mg per 10 mL; 20 mg per 20 mL
Indications:
- Unspecified malignant neoplasms of ill-defined or unspecified sites
- Other specified gliomas of brain
- Other specified malignant neoplasms of the ovary
- Other specified malignant neoplasms of bronchus or lung
- Malignant neoplasms of nasopharynx
- Germ cell tumour of testis
- Malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx
- Osteosarcoma of bone and articular cartilage of unspecified sites
- Malignant neoplasms of cervix uteri
- Malignant neoplasms of hypopharynx
- Malignant neoplasms of oropharynx
Source: EML workbook import
Product metadata will be available once the catalog entry is complete.
Formulations:
- Parenteral > General injections > unspecified: 10 mg in vial powder for injection; 50 mg in vial powder for injection
Parenteral > General injections > IV: 10 mg per 10 mL; 20 mg per 20 mL; 50 mg per 50 mL; 100 mg per 100 mL
Parenteral > General injections > IV: 50 mg per 50 mL; 100 mg per 100 mL; 10 mg per 10 mL; 20 mg per 20 mL
Indications:
- Unspecified malignant neoplasms of ill-defined or unspecified sites
- Other specified gliomas of brain
- Other specified malignant neoplasms of the ovary
- Other specified malignant neoplasms of bronchus or lung
- Malignant neoplasms of nasopharynx
- Germ cell tumour of testis
- Malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx
- Osteosarcoma of bone and articular cartilage of unspecified sites
- Malignant neoplasms of cervix uteri
- Malignant neoplasms of hypopharynx
- Malignant neoplasms of oropharynx
Source: EML workbook import